SEARCH

SEARCH BY CITATION

References

  • 1
    Johansson SGO, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113:832836.
  • 2
    Demoly P, Pichler W, Pirmohamed M, Romano A. Important questions in Allergy: 1–drug allergy/hypersensitivity. Allergy 2008;63:616619.
  • 3
    Pichler WJ. Drug hypersensitivity reactions: classification and relationship to t-cell activation. In: Pichler WJ editor. Drug Hypersensitivity. Basel: Karger, 2007: 168189.
  • 4
    Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986;256:33583363.
  • 5
    Cernadas JR, Brockow K, Romano A, Aberer W, Torres MJ, Bircher A et al. General considerations on rapid desensitization for drug hypersensitivity – a consensus statement. Allergy 2010;65:13571366.
  • 6
    Khan D, Solensky R. Drug allergy. J Allergy Clin Immunol 2010;125:S126S137.
  • 7
    Boxer MB, Dykewicz MS, Patterson R, Greenberger PA, Kelly JF. The management of patients with sulfonamide allergy. N Engl Reg Allergy Proc 1988;9:219223.
  • 8
    Shafer RW, Seitzman PA, Tapper ML. Successful prophylaxis of Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole in AIDS patients with previous allergic reactions. J Acquir Immune Defic Syndr 1989;2:389393.
  • 9
    Putterman C, Rahav G, Shalit M, Rubinow A. ‘Treating through’ hypersensitivity to co-trimoxazole in AIDS patients. Lancet 1990;336:52.
  • 10
    Lin D, Li W, Rieder M. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole. Cochrane Database Syst Rev, 2007; 2:CD005646.
  • 11
    Jung AC, Paauw DS. Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients. Arch Intern Med 1994;154:24022406.
  • 12
    Nijsten T, Meuleman L, Schroyens W, Lambert J. Thalidomide-induced morbilliform rash: diagnosis and continuation of therapy, premedicated with methylprednisolone. Dermatology 2002;204:365367.
  • 13
    Solensky R. Drug desensitization. Immunol Allergy Clin North Am 2004;24:425443.
  • 14
    Solensky R. Desensitization with antibiotics. In: Pichler WJ editor. Drug Hypersensitivity. Basel: Karger, 2007: 404412.
  • 15
    Solensky R. Drug hypersensitivity. Med Clin North Am 2006;90:233260.
  • 16
    Pichler W. Delayed drug hypersensitivity reactions. Ann Intern Med 2003;139:683693.
  • 17
    Aster RH. Blood dyscrasias caused by hypersensitivity to drugs. In: Pichler WJ editor. Drug Hypersensitivity. Basel: Karger, 2007: 306320.
  • 18
    Teraki Y, Shiohara T. Successful desensitization to fixed drug eruption: the presence of CD25+ CD4+ T cells in the epidermis of fixed drug eruption lesions may be involved in the induction of desensitization. Dermatology 2004;209:2932.
  • 19
    Whitaker P, Shaw N, Gooi J, Etherington C, Conway S, Peckham D. Rapid desensitization for non-immediate reactions in patients with cystic fibrosis. J Cyst Fibros 2011;10:282285.
  • 20
    Mockenhaupt M. Epidemiology and causes of severe cutaneous adverse reactions to drugs. In: Pichler WJ editor. Drug Hypersensitivity. Basel: Karger, 2007: 1831.
  • 21
    Ruano FJ, Garcimartin MI, Vazquez de la Torre M, Blanca M, Canto G. Desensitization of epoetin-α in a confirmed case of acute exanthematic pustulosis. Allergy 2009;64:17971798.
  • 22
    Executive summary of disease management of drug hypersensitivity: a practice parameter. Ann Allergy Asthma Immunol 1999;83:665666.
  • 23
    Douglas R, Spelman D, Czarny D, O'Hehir Robyn E. Successful desensitization of two patients who previously developed Stevens–Johnson syndrome while receiving trimethoprim-sulfamethoxazole. Clin Infect Dis 1997;25:1480.
  • 24
    MacLean Smith R, Iwamoto GK, Richerson HB, Flaherty JP. Trimethoprim-sulfamethoxazole desensitization in the acquired immunodeficiency syndrome. Ann Intern Med 1987;106:335.
  • 25
    Papakonstantinou G, Füessl H, Matuschke A, Hehlmann R. Therapy of pneumocystis carinii pneumonia after trimethoprimsulfamethoxazole desensitization. Klin Wochenschr 1989;67:316.
  • 26
    Papakonstantinou G, Füessl H, Hehlmann R. Trimethoprim-sulfamethoxazole desensitization in AIDS. Klin Wochenschr 1988;66:351353.
  • 27
    Kohli-Pamnani A, Huynh P, Lobo F. Amprenavir-induced maculopapular exanthem followed by desensitization in a patient with late-stage human immunodeficiency virus. Ann Allergy Asthma Immunol 2006;96:620623.
  • 28
    Phillips EJ, Kuriakose B, Knowles SR. Efavirenz-induced skin eruption and successful desensitization. Ann Pharmacother 2002;36:430432.
  • 29
    Duque S, de la Puente J, Rodríguez F, Pellón LF, Maquiera E, Jerez J. Zidovudine-related erythroderma and successful desensitization: a case report. J Allergy Clin Immunol 1996;98:234235.
  • 30
    Carr A, Penny R, Cooper DA. Allergy and desensitization to zidovudine in patients with acquired immunodeficiency syndrome (AIDS). J Allergy Clin Immunol 1993;91:683685.
  • 31
    Borish L, Tamir R, Rosenwasser LJ. Intravenous desensitization to beta-lactam antibiotics. J Allergy Clin Immunol 1987;80:314319.
  • 32
    Demoly P, Messaad D, Sahla H, Fabre J, Faucherre V, Andr P et al. Six-hour trimethoprim-sulfamethoxazole-graded challenge in HIV-infected patients. J Allergy Clin Immunol 1998;102:10331036.
  • 33
    Demoly P, Messaad D, Reynes J, Faucherre V, Bousquet J. Trimethoprim-sulfamethoxazole-graded challenge in HIV-infected patients: long-term follow-up regarding efficacy and safety. J Allergy Clin Immunol 2000;105:588589.
  • 34
    Wessbecher R, Stangl S. Management of tolerance induction in patients with suspected penicillin allergy – a case study. Int J Dermatol 2009;48:488491.
  • 35
    Bircher AJ, Rutishauser M. Oral ‘desensitization’ of maculopapular exanthema from ciprofloxacin. Allergy 1997;52:12461248.
  • 36
    Fam AG, Lewtas J, Stein J, Paton TW. Desensitization to allopurinol in patients with gout and cutaneous reactions. Am J Med 1992;93:299302.
  • 37
    Fam AG, Dunne SM, Iazzetta J, Paton TW. Efficacy and safety of desensitization to allopurinol following cutaneous reactions. Arthritis Rheum 2001;44:231238.
  • 38
    Belchí-Hernández J, Espinosa-Barra FJ. Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection. Ann Allergy Asthma Immunol 1996;76:355358.
  • 39
    Purdy BH, Philips DM, Summers RW. Desensitization for sulfasalazine skin rash. Ann Intern Med 1984;100:512514.
  • 40
    Cameron W, Windt M, Borish L, Tamir R, Rosenwasser L, Rocklin R. A complicated case of penicillin allergy. Ann Allergy 1984;53:455461.
  • 41
    Gompels MM, Simpson N, Snow M, Spickett G, Ong E. Desensitization to co-trimoxazole (trimethoprim-sulphamethoxazole) in HIV-infected patients: is patch testing a useful predictor of reaction? J Infect 1999;38:111115.
  • 42
    Leoung GS, Stanford JF, Giordano MF, Stein A, Torres RA, Giffen CA et al. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ. J Infect Dis 2001;184:992997.
  • 43
    Fegueux S, Jruchis PD, Ballout H, Maslo C, Matheron S, Coulaud J-P. Sulphadiazine desensitization in AIDS patients. AIDS 1991;5:1275.
  • 44
    Caumes E, Guermonprez G, Winter C, Katlama C, Bricaire F. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus. Clin Infect Dis 1996;23:13131314.
  • 45
    Anderson JA. Antibiotic drug allergy in children. Curr Opin Pediatr 1994;6:656660.
  • 46
    Stricker RB, Gullett JH, Williams LE, Goldberg B. Co-trimoxazole desensitization syndrome: delayed hematologic toxicity complicating prophylactic therapy in AIDS patients. AIDS 1996;10:927929.
  • 47
    Romano A, Artesani M, Andriolo M, Viola M, Pettinato R, Vecchioli-Scaldazza A. Effective prophylactic protocol in delayed hypersensitivity to contrast media: report of a case involving lymphocyte transformation studies with different compounds. Radiology 2002;225:466470.
  • 48
    Courvoisier S, Bircher AJ. Delayed-type hypersensitivity to a nonionic, radiopaque contrast medium. Allergy 1998;53:12211224.
  • 49
    Arnold AW, Hausermann P, Bach S, Bircher AJ. Recurrent flexural exanthema (SDRIFE or baboon syndrome) after administration of two different iodinated radio contrast media. Dermatology 2007;214:8993.
  • 50
    Horne NW, Grant IW. Development of drug resistance to isoniazid during desensitization: a report of two cases. Tubercle 1963;44:180182.
  • 51
    Drira I, Souissi R, Dakhlaoui R, Jeguirim MS, Chebbi ML. Oral desensitization to antitubercular agents. Rev Pneumol Clin 1997;53:104106.
  • 52
    Barbaud A. Skin testing in delayed reactions to drugs. Immunol Allergy Clin North Am 2009;29:517535.
  • 53
    Pichler WJ, Adam J, Daubner B, Gentinetta T, Keller M, Yerly D. Drug hypersensitivity reactions: pathomechanism and clinical symptoms. In: Pichler WJ, Glover R editors: Drug Hypersensitivity: Medical Clinics of North America, vol 94. Philadelphia: W.B. Saunders Company, 2010: 645664.